Skip to main content
logo
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
4.030
-0.290 (-6.71%)
At close: Oct 23, 2026, 4:00 PM EDT
4.011
-0.019 (-0.46%)
After-hours: Oct 23, 2026, 7:43 PM EDT

ARS Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
116.9384.2889.150.031.325.51
Revenue Growth
4.08%-5.46%297063.33%-97.72%-76.10%-69.13%
Gross Profit
68.2250.6768.59-20.24-15.8-14.77
Operating Income
-216.27-179.45-3.08-67.52-34.46-19.45
Net Income
-215.43-171.38-54.37-34.68-20.24
Earnings Per Share
-2.18-1.740.08-0.57-0.87-0.70
EPS Growth
------

Revenue by Geography
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
95.2972.197.260.031.325.51
Rest of World
18.9612.0981.89---
Total
116.9384.2889.150.031.325.51

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
143.85244.99314.02228.36274.3860.06
Total Debt
171.6168.5169.380.270.489.03
Net Cash (Debt)
-27.7676.47244.64228.09273.951.03
Net Cash Growth
--68.74%7.26%-16.73%436.74%251.86%
Net Cash Per Share
-0.280.782.392.406.861.77

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-196.41-170.8713.55-59.27-40.08-17.56
Capital Expenditures
-0.2-0.34-0.56-0.18-0.2-0.06
Free Cash Flow
-196.6-171.2112.99-59.44-40.28-17.62
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
58.35%60.13%76.94%---268.20%
Operating Margin
-184.96%-212.92%-3.46%-225066.67%-2618.54%-353.32%
Pretax Margin
-184.31%-203.35%9.29%-181216.67%-2635.41%-367.65%
Profit Margin
-184.25%-203.25%8.97%-181216.67%-2635.41%-367.65%
FCF Margin
-168.14%-203.14%14.57%-198136.67%-3060.56%-319.94%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--128.20---
P/FCF Ratio
--78.96---
PS Ratio
3.4313.6611.5017535.50607.80-